An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Among asthma patients infected with COVID-19, those who received the antiviral drug nirmatrelvir-ritonavir (Paxlovid) had ...

Researchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a ...

Ritonavir showed a binding affinity of −8.9 kcal/mol, interacting with residues ARG148, ASN130, VAL23, SER81, ASN33, PHE29, TYR33, SER31, ASN132, ALA26, ALA30, ALA34, and TYR133.Molecular ...

Antimicrobial resistance (AMR) is predicted to cause 10 million deaths every year by 2050. Since its identification more than 50 years ago, pleuromutilin has served as a scaffold for the development ...

Study: Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.

Norethindrone acetate 1mg, ethinyl estradiol 10micrograms (24 tabs), ethinyl estradiol 10micrograms (2 tabs); inert+ (2 tabs); +contains ferrous fumarate 75mg. High risk of arterial or venous ...